Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PKRA83 is a potent prokineticin (PK2) antagonist that crosses the blood-brain barrier and competes for PK2 binding to its receptors PKR1 and PKR2. PKRA83 effectively inhibits PK2 receptors and acts on PKR1 (IC50: 5.0 nM) and PKR2 (IC50: 8.2 nM). PKRA83 exhibits anti-cancer and anti-angiogenic effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 753.00 | |
50 mg | 6-8 weeks | $ 979.00 | |
100 mg | 6-8 weeks | $ 1,740.00 |
Description | PKRA83 is a potent prokineticin (PK2) antagonist that crosses the blood-brain barrier and competes for PK2 binding to its receptors PKR1 and PKR2. PKRA83 effectively inhibits PK2 receptors and acts on PKR1 (IC50: 5.0 nM) and PKR2 (IC50: 8.2 nM). PKRA83 exhibits anti-cancer and anti-angiogenic effects. |
Molecular Weight | 505.02 |
Formula | C27H34ClFN2O4 |
CAS No. | 1233926-87-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PKRA83 1233926-87-8 inhibitor inhibit